Silexion Therapeutics Files S-1/A, Reverse Stock Split
Ticker: SLXNW · Form: S-1/A · Filed: Mar 27, 2025 · CIK: 2022416
Sentiment: neutral
Topics: S-1/A, reverse-stock-split, corporate-action
TL;DR
Silexion (formerly Biomotion) filed an S-1/A, doing a 1-for-9 reverse split. Watch for share structure changes.
AI Summary
Silexion Therapeutics Corp. filed an S-1/A on March 27, 2025, to update its registration statement. The company, formerly known as Biomotion Sciences until May 6, 2024, is undergoing a 1-for-9 reverse share split. Their business address is 12 Abba Hillel Road, Ramat Gan, Israel.
Why It Matters
This S-1/A filing indicates ongoing regulatory activity and corporate restructuring for Silexion Therapeutics, potentially impacting its stock structure and investor relations.
Risk Assessment
Risk Level: medium — S-1/A filings often precede significant corporate actions like stock splits or offerings, which can introduce volatility and uncertainty for investors.
Key Numbers
- 1-for-9 — Reverse Share Split (Indicates a significant change in the number of outstanding shares.)
- 20250327 — Filing Date (The date the S-1/A was filed with the SEC.)
Key Players & Entities
- Silexion Therapeutics Corp (company) — Filer of the S-1/A
- Biomotion Sciences (company) — Former name of Silexion Therapeutics Corp
- 20250327 (date) — Filing date of the S-1/A
- 1-for-9 (reverse_stock_split) — Stock split ratio mentioned in the filing
- 0002022416 (company_id) — Central Index Key for Silexion Therapeutics Corp
FAQ
What is the primary purpose of this S-1/A filing for Silexion Therapeutics Corp?
The S-1/A filing is an amendment to a previous registration statement, and it specifically mentions adjustments to share amounts to reflect a 1-for-9 reverse share split.
When did Silexion Therapeutics Corp. change its name from Biomotion Sciences?
The date of the name change from Biomotion Sciences to Silexion Therapeutics was May 6, 2024 (20240506).
What is the business address of Silexion Therapeutics Corp?
The business address is 12 Abba Hillel Road, Ramat Gan, L3 5250606, Israel.
What is the SIC code for Silexion Therapeutics Corp?
The Standard Industrial Classification (SIC) code is 2836, which corresponds to Biological Products (No Diagnostic Substances).
What does the filing indicate about the company's share structure?
The filing explicitly states that all share amounts have been retroactively adjusted to reflect a 1-for-9 reverse share split.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on March 27, 2025 regarding Silexion Therapeutics Corp (SLXNW).